- Preprint Article
- 10.64898/2026.02.20.26346678
Investigation of the correlation of adropin with anthropological and psychological factors in schizophrenia: preliminary evidence from a case-control study
- Feb 28, 2026
- medRxiv
- Yuko Nishida + 5 more +5
Abstract Background and Hypothesis Schizophrenia is a disease characterized by various symptoms and has severe lifelong impacts on patients and their families. Despite various hypotheses and associated studies, the key mechanism in schizophrenia is not fully elucidated. In the present study, we focused on adropin, a peptide regulating energy metabolism, antioxidation, and neuroprotection. Study Design In both the group of healthy volunteers (HV) and the group of patients with some schizophrenia spectrum and other psychotic disorders (SZ), we evaluated adropin along with other variables such as anthropological factors, psychological well-being indicators, and laboratory test results. Study Results The adropin levels in SZ were not significantly different from those in HV. Correlation analysis indicated five significant correlations beyond various natural correlations arising from fundamental proportional relationships and multifaceted psychological well-being indicators: (1) adropin versus right handgrip strength in the SZ group (τ = –0.82, P = 0.066); (2) adropin versus selenium in the total group (τ = 0.44, P = 0.053); (3) ferritin versus perceived stress in the total group (τ = –0.44, P = 0.053); (4) right versus left handgrip strength in the total group (τ = 0.70, P = 0.001) and in the SZ group (τ = 0.82, P = 0.075); and (5) selenium versus state anxiety in the total group (τ = 0.44, P = 0.053) and the SZ group (τ = 0.84, P = 0.066). Conclusions The present study provides a foundation for future studies and sheds light on the role of adropin in schizophrenia.
Read more